Inhibitor Therapeutics, Inc. (INTI) › Total AssetsInhibitor Therapeutics, Inc. (INTI) — Total AssetsAnnual figures by fiscal year, from SEC filings.2012: $936.4K2013: $10.2K2014: $463.0K2015: $885.9K2016: $7.34M2017: $768.1K2018: $1.23M2019: $900.0K2020: $131.8K2021: $58.8K2022: $11.98M2023: $8.95M2024: $5.69M2025: $2.51M$2.51M2012Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$2.51M-55.9%2024$5.69M-36.4%2023$8.95M-25.3%2022$11.98M+20271.4%2021$58.8K-55.4%2020$131.8K-85.4%2019$900.0K-27.0%2018$1.23M+60.5%2017$768.1K-89.5%2016$7.34M+728.4%2015$885.9K+91.3%2014$463.0K+4431.4%2013$10.2K-98.9%2012$936.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share